Biochanin A as an α-hemolysin inhibitor for combating methicillin-resistant Staphylococcus aureus infection
- PMID: 34837116
- DOI: 10.1007/s11274-021-03182-4
Biochanin A as an α-hemolysin inhibitor for combating methicillin-resistant Staphylococcus aureus infection
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a multidrug-resistant pathogen that poses a significant risk to global health today. In S. aureus, α-hemolysin is an important virulence factor as it contributes to the capacity of the bacteria to infect the host. Here, we showed that biochanin A (bioA), an isoflavone present in red clover, cabbage and alfalfa, effectively inhibited hemolytic activity at a dose as low as 32 μg/mL. Further, western blot and RT-qPCR data showed that bioA reduced the production and expression of MRSA hemolysin in a dose-dependent manner. In addition, when different concentrations of bioA were added to a coculture system of A549 cells and S. aureus, it could significantly decrease cell injury. Importantly, the in vivo study showed that bioA could protect mice from pneumonia caused by a lethal dose of MRSA, as evidenced by improving their survival and reducing the number of bacterial colonies in lung tissues, the secretion of hemolysin into alveolar lavage fluid and the degree of pulmonary edema. In conclusion, biochanin A protected the host from MRSA infection by inhibiting the expression of the hemolysin of MRSA, which may provide experimental evidence for its development to a potential anti-MRSA drug.
Keywords: Antivirulence; Biochanin A; Methicillin-resistant Staphylococcus aureus; α-Hemolysin.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.
References
-
- Bernheimer AW, Schwartz LL (1963) Isolation and composition of staphylococcal alpha toxin. J Gen Microbiol 30:455–468. https://doi.org/10.1099/00221287-30-3-455 - DOI - PubMed
-
- Berube BJ, Bubeck Wardenburg J (2013) Staphylococcus aureus α-toxin: nearly a century of intrigue. Toxins 5(6):1140–1166. https://doi.org/10.3390/toxins5061140 - DOI - PubMed - PMC
-
- Bhakdi S, Muhly M, Füssle R (1984) Correlation between toxin binding and hemolytic activity in membrane damage by staphylococcal alpha-toxin. Infect Immun 46(2):318–323. https://doi.org/10.1128/iai.46.2.318-323.1984 - DOI - PubMed - PMC
-
- Brown EL, Dumitrescu O, Thomas D, Badiou C, Koers EM, Choudhury P, Vazquez V, Etienne J, Lina G, Vandenesch F, Bowden MG (2009) The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin Microbiol Infect 15(2):156–164. https://doi.org/10.1111/j.1469-0691.2008.02648.x - DOI - PubMed - PMC
-
- Bubeck Wardenburg J, Patel RJ, Schneewind O (2007) Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect Immun 75(2):1040–1044. https://doi.org/10.1128/iai.01313-06 - DOI - PubMed
MeSH terms
Substances
Grants and funding
- 2019/Xinglin Scholar Project" of Changchun University of Chinese Medicine
- 20190103080JH/Science and Technology Development Plan Project (2019) of Jilin Province Science and Technology Department
- No. JJKH20200906KJ/"Thirteenth Five-Year Plan" of Science and Technology Project of Education Department of Jilin Province
LinkOut - more resources
Full Text Sources
Medical